C/EBPβ functions as a critical transcription factor involved in neuroinflammation and has emerged as a potential target for therapeutic interventions in various neurodegenerative diseases (Pulido‐Salgado et al., 2015). This evidence concerns the gene CEBPB and neurodegenerative disease.